• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


2.7100 USD 0.1100 3.90%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Zogenix Inc (ZGNX)

Open: 2.8300 Day's Range: 2.6600 - 2.9400 Volume: 3,848,414
Previous Close: 2.8200 52wk Range: 1.2500 - 5.1900 1-Yr Rtn: +69.38%

Stock Chart for ZGNX

No chart data available.
  • ZGNX:US 2.7100
  • 1D
  • 1M
  • 1Y
Interactive ZGNX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZGNX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5622
Est. EPS (USD) (12/2014) -0.6230
Est. PEG Ratio -
Market Cap (M USD) 378.15
Shares Outstanding (M) 139.54
30 Day Average Volume 4,272,631
Price/Book (mrq) 20.4327
Price/Sale (ttm) 8.9158
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZGNX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ZGNX

Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.

Roger L HawleyCEO/Co-FounderStephen J FarrPresident/Co-Founder
Ann D RhoadsExec VP/CFO/Treasurer/SecyBradley Stuart Galer "Brad Gale"Exec VP/Chief Medical Officer
More Company Profile & Key Executives for ZGNX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil